Skip to main content

Table 2 Relationship between CDX2 expression and survival in patients after potentially curative liver metastasectomy

From: Impact of CDX2 expression status on the survival of patients after curative resection for colorectal cancer liver metastasis

Survival (days)

CDX2 expression

Univariate HR (95% CI)

P value

High

Low

Median DFS

420

245

1.53 (1.03–2.26)

0.032

Median OS

3145

1024

2.45 (1.55–3.86)

< 0.001

  1. HR Hazard ratio, OS Overall survival, DFS Disease-free survival